Thailand Non-alcoholic Steatohepatitis Market (2025-2031) | Trends, Share, Analysis, Industry, Growth, Value, Competitive Landscape, Companies, Size & Revenue, Outlook, Forecast, Segmentation

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Thailand Country Macro Economic Indicators

3.2 Thailand Non-alcoholic Steatohepatitis Market Revenues & Volume, 2021 & 2031F

3.3 Thailand Non-alcoholic Steatohepatitis Market - Industry Life Cycle

3.4 Thailand Non-alcoholic Steatohepatitis Market - Porter's Five Forces

3.5 Thailand Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

3.6 Thailand Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F

3.7 Thailand Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By Disease Cause, 2021 & 2031F

3.8 Thailand Non-alcoholic Steatohepatitis Market Revenues & Volume Share, By End User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of obesity and diabetes in Thailand leading to a higher incidence of non-alcoholic steatohepatitis (NASH).

4.2.2 Growing awareness among healthcare professionals and patients about the risks and consequences of NASH.

4.2.3 Government initiatives and healthcare policies focusing on addressing metabolic disorders and liver diseases.

4.3 Market Restraints

4.3.1 Limited availability of approved treatments specific to NASH in Thailand.

4.3.2 High costs associated with NASH diagnostics and treatment options.

4.3.3 Lack of standardized guidelines for the diagnosis and management of NASH in the country.

6.1 Thailand Non-alcoholic Steatohepatitis Market, By Drug Type

6.1.1 Overview and Analysis

6.1.2 Thailand Non-alcoholic Steatohepatitis Market Revenues & Volume, By Drug Type, 2021- 2031F

6.1.3 Thailand Non-alcoholic Steatohepatitis Market Revenues & Volume, By Vitamin E and Pioglitazone, 2021- 2031F

6.1.4 Thailand Non-alcoholic Steatohepatitis Market Revenues & Volume, By Ocaliva, 2021- 2031F

6.1.5 Thailand Non-alcoholic Steatohepatitis Market Revenues & Volume, By Elafibranor, 2021- 2031F

6.1.6 Thailand Non-alcoholic Steatohepatitis Market Revenues & Volume, By Selonsertib and Cenicriviroc, 2021- 2031F

6.1.7 Thailand Non-alcoholic Steatohepatitis Market Revenues & Volume, By Obeticholic Acid, 2021- 2031F

6.1.8 Thailand Non-alcoholic Steatohepatitis Market Revenues & Volume, By Others, 2021- 2031F

6.2 Thailand Non-alcoholic Steatohepatitis Market, By Sales Channel

6.2.1 Overview and Analysis

6.2.2 Thailand Non-alcoholic Steatohepatitis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.2.3 Thailand Non-alcoholic Steatohepatitis Market Revenues & Volume, By Online Providers, 2021- 2031F

6.2.4 Thailand Non-alcoholic Steatohepatitis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.3 Thailand Non-alcoholic Steatohepatitis Market, By Disease Cause

6.3.1 Overview and Analysis

6.3.2 Thailand Non-alcoholic Steatohepatitis Market Revenues & Volume, By Hypertension, 2021- 2031F

6.3.3 Thailand Non-alcoholic Steatohepatitis Market Revenues & Volume, By Heart Disease, 2021- 2031F

6.3.4 Thailand Non-alcoholic Steatohepatitis Market Revenues & Volume, By High Blood Lipid, 2021- 2031F

6.3.5 Thailand Non-alcoholic Steatohepatitis Market Revenues & Volume, By Type 2 Diabetes, 2021- 2031F

6.3.6 Thailand Non-alcoholic Steatohepatitis Market Revenues & Volume, By Obesity, 2021- 2031F

6.4 Thailand Non-alcoholic Steatohepatitis Market, By End User

6.4.1 Overview and Analysis

6.4.2 Thailand Non-alcoholic Steatohepatitis Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 Thailand Non-alcoholic Steatohepatitis Market Revenues & Volume, By Clinics, 2021- 2031F

6.4.4 Thailand Non-alcoholic Steatohepatitis Market Revenues & Volume, By Homecare settings, 2021- 2031F

7.1 Thailand Non-alcoholic Steatohepatitis Market Export to Major Countries

7.2 Thailand Non-alcoholic Steatohepatitis Market Imports from Major Countries

8.1 Average time from NASH diagnosis to treatment initiation.

8.2 Percentage of healthcare providers trained in NASH diagnosis and management.

8.3 Patient adherence to recommended lifestyle modifications for NASH management.

9.1 Thailand Non-alcoholic Steatohepatitis Market Opportunity Assessment, By Drug Type, 2021 & 2031F

9.2 Thailand Non-alcoholic Steatohepatitis Market Opportunity Assessment, By Sales Channel, 2021 & 2031F

9.3 Thailand Non-alcoholic Steatohepatitis Market Opportunity Assessment, By Disease Cause, 2021 & 2031F

9.4 Thailand Non-alcoholic Steatohepatitis Market Opportunity Assessment, By End User, 2021 & 2031F

10.1 Thailand Non-alcoholic Steatohepatitis Market Revenue Share, By Companies, 2024

10.2 Thailand Non-alcoholic Steatohepatitis Market Competitive Benchmarking, By Operating and Technical Parameters